Vertex Pharmaceuticals to acquire Alpine Immune Sciences in $4.9 billion deal
Vertex Pharmaceuticals Incorporated (VRTX) has announced its plans to acquire Alpine Immune Sciences, Inc. (ALPN), a company dedicated to the discovery and development of novel...